Leading a new era in bone marrow transplant medicine

We are developing novel medicines to transform all aspects of bone marrow transplant and create a life-saving platform for many diseases.

Learn more
Acute Myeloid Leukemia survivor Gayle. Read her story.
A Curative Vision

We are expanding the curative potential of bone marrow transplant to more patients who can benefit. We are advancing a broad portfolio of products in development, including our most advanced program, MGTA-456, which is currently being studied in Phase 1/2 clinical trials.

Learn more
Focus on Patients

Today bone marrow transplants are complicated, toxic and high-risk. We are working to change that for patients with autoimmune diseases, blood cancers, and rare genetic diseases.

Learn more
Our Culture

What inspires Magenta?
Equal parts Courage, Commitment and Excellence.

Learn more

Leading a new era in bone marrow transplant medicine

Social Media

@magentatx December 11, 2017
We are so proud of our own Kevin Goncalves, presenting impressive research on stem cell expansion in B216-217 now! #ASH17

See us on Twitter